What is Lumen Bioscience's official website?

Lumen Bioscience's website is lumenbioscience.com

How many employees are working in Lumen Bioscience right now?

Lumen Bioscience has 99 employees.

What is Lumen Bioscience's industry?

Lumen Bioscience's industry is Biotechnology Research

Who are Lumen Bioscience's top competitors?

Lumen Bioscience's top competitors are , , , , , ,

Lumen Bioscience company information, Employees & Contact Information

Explore related pages

Lumen Bioscience email format Lumen Bioscience management contacts

Related company profiles:

Lumen Bioscience develops oral antibody therapeutics.

Employees: 99
Founded: -
Address: Seattle, Wa, Us
Phone: 206-899-1904
Industry: Biotechnology Research
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)
Website: lumenbioscience.com
Keywords: Industrial biotechnology, Cyanobacteria, Pigments, Animal Health.
HQ: Seattle, WA
Competitors: Shape Therapeutics Inc., A-Alpha Bio, SystImmune, Parse Biosciences, Starfish Neuroscience, Evolved Therapeutics, Moonlight Bio, Kapoose Creek Bio, Adaptive Biotechnologies Corp., HDT Bio.

Lumen Bioscience Questions

News

Lumen Bioscience Expands Board and Leadership Team to Advance Clinical Pipeline of Novel Oral Biologics - PR Newswire

Lumen Bioscience Expands Board and Leadership Team to Advance Clinical Pipeline of Novel Oral Biologics PR Newswire

Fresh off $30M round, Seattle startup Lumen Bioscience adds Microsoft vet Jeff Raikes to board - GeekWire

Fresh off $30M round, Seattle startup Lumen Bioscience adds Microsoft vet Jeff Raikes to board GeekWire

Lumen Bioscience raises $30M Series C extension - Axios

Lumen Bioscience raises $30M Series C extension Axios

The latest on Lumen Biosience's experimental c. diff biologic - drugdiscoverytrends.com

The latest on Lumen Biosience's experimental c. diff biologic drugdiscoverytrends.com

Lumen Bioscience's LMN-201 Achieves 100% Initial C. difficile Clinical Cure in Preliminary Cohort of RePreve Trial - PR Newswire

Lumen Bioscience's LMN-201 Achieves 100% Initial C. difficile Clinical Cure in Preliminary Cohort of RePreve Trial PR Newswire

Lumen Bioscience wins historic $1.5M Wilkes Center Climate Prize - The University of Utah

Lumen Bioscience wins historic $1.5M Wilkes Center Climate Prize The University of Utah

Lumen Bioscience Wins USDA Grant to Develop Oral Vaccine to Protect Farmed Fish - SynBioBeta

Lumen Bioscience Wins USDA Grant to Develop Oral Vaccine to Protect Farmed Fish SynBioBeta

The Escalator: Eli Lilly, Nuvalent, Lumen Bioscience and more - Medical Marketing and Media

The Escalator: Eli Lilly, Nuvalent, Lumen Bioscience and more Medical Marketing and Media

Lumen Bioscience data show needle free spirulina-produced vaccination protects against malaria - Labiotech.eu

Lumen Bioscience data show needle free spirulina-produced vaccination protects against malaria Labiotech.eu

Lumen Raises $13M for New Biotech Production Platform - SynBioBeta

Lumen Raises $13M for New Biotech Production Platform SynBioBeta

Lumen Bioscience pursues oral biologic to prevent recurrent C. diff - drugdiscoverytrends.com

Lumen Bioscience pursues oral biologic to prevent recurrent C. diff drugdiscoverytrends.com

Seattle startup Lumen Bioscience to build algae manufacturing plant in former bakery - GeekWire

Seattle startup Lumen Bioscience to build algae manufacturing plant in former bakery GeekWire

Lumen Bioscience Details 2022 Company and Facilities Growth, New Funding, and Clinical Pipeline Progress - PR Newswire

Lumen Bioscience Details 2022 Company and Facilities Growth, New Funding, and Clinical Pipeline Progress PR Newswire

Seattle startup Lumen Bioscience is working with Google to make drugs using algae - GeekWire

Seattle startup Lumen Bioscience is working with Google to make drugs using algae GeekWire

Lumen Bioscience Receives Fast Track Designation from U.S. FDA for LMN-201 - PR Newswire

Lumen Bioscience Receives Fast Track Designation from U.S. FDA for LMN-201 PR Newswire

Lumen Bioscience awarded $16.2 million in DoD funding to advance LMN-201 through late-stage trials - PR Newswire

Lumen Bioscience awarded $16.2 million in DoD funding to advance LMN-201 through late-stage trials PR Newswire

Lumen Bioscience and Novo Nordisk Enter into Research Collaboration to Explore Novel Strategies to Deliver Oral Biologics for Cardiometabolic Disease - PR Newswire

Lumen Bioscience and Novo Nordisk Enter into Research Collaboration to Explore Novel Strategies to Deliver Oral Biologics for Cardiometabolic Disease PR Newswire

Lumen Bioscience Awarded $8.1 million from U.S. Department of Defense to Develop Fast-Acting, Intranasal Countermeasure Against Respiratory Viruses - PR Newswire

Lumen Bioscience Awarded $8.1 million from U.S. Department of Defense to Develop Fast-Acting, Intranasal Countermeasure Against Respiratory Viruses PR Newswire

Lumen Bioscience Announces Publication in Nature Biotechnology Detailing Spirulina-Based Platform for Ultra-Large-Scale Production of Therapeutic Proteins - PR Newswire

Lumen Bioscience Announces Publication in Nature Biotechnology Detailing Spirulina-Based Platform for Ultra-Large-Scale Production of Therapeutic Proteins PR Newswire

Lumen Bioscience Hacks Spirulina to Generate Biologics - Genetic Engineering and Biotechnology News

Lumen Bioscience Hacks Spirulina to Generate Biologics Genetic Engineering and Biotechnology News

Lumen Bioscience Raises $16M Series B Financing to Accelerate Clinical Development of Accessible Biologic Drugs - Business Wire

Lumen Bioscience Raises $16M Series B Financing to Accelerate Clinical Development of Accessible Biologic Drugs Business Wire

On the Horizon, Needle-Free Vaccines could Offer Better Protection and Access - BioSpace

On the Horizon, Needle-Free Vaccines could Offer Better Protection and Access BioSpace

Companies like Lumen Bioscience

Top Lumen Bioscience Employees

Brian Finrow

n/a

Seattle, Washington, United States, United States

View

7
netscape.net, cooley.com, adaptivebiotech.com, cooley.com, gmail.com, lumenbioscience.com, lumen.bio

8 +120666XXXXX
Sebastian Mikolajczak

n/a

Seattle, Washington, United States, United States

View
Rob Carlson

Managing Director At Planetary…

Seattle, Washington, United States, United States

View

5
bioeconomycapital.com, synthesis.cc, paulhastings.com, sidley.com, paulhastings.com
John Morrow

Coo And Gc At Lumen Bioscience |…

N/a

View

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles

Get direct phone numbers & mobile contacts

Access company data & employee information

Works directly on LinkedIn - no copy/paste needed

Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Learn More

How It Works

Get a Free Account

Search the #1 Contact Database

Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.

Use our AI-Powered Email Finder

Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.

Have a look at Aeroleads Data

Browse our Data

Company Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Profile Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

List Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Lumen Bioscience company information, Employees & Contact Information

Explore related pages

Company Details

Lumen Bioscience Questions

What is Lumen Bioscience's helpline number?

What is Lumen Bioscience's official website?

What is Lumen Bioscience's LinkedIn profile?

How many employees are working in Lumen Bioscience right now?

What is Lumen Bioscience's industry?

What are Lumen Bioscience's top competitors?

What are Lumen Bioscience's categories?

When was Lumen Bioscience founded?

News

Lumen Bioscience Expands Board and Leadership Team to Advance Clinical Pipeline of Novel Oral Biologics - PR Newswire

Fresh off $30M round, Seattle startup Lumen Bioscience adds Microsoft vet Jeff Raikes to board - GeekWire

Lumen Bioscience raises $30M Series C extension - Axios

The latest on Lumen Biosience's experimental c. diff biologic - drugdiscoverytrends.com

Lumen Bioscience's LMN-201 Achieves 100% Initial C. difficile Clinical Cure in Preliminary Cohort of RePreve Trial - PR Newswire

Lumen Bioscience wins historic $1.5M Wilkes Center Climate Prize - The University of Utah

Lumen Bioscience Wins USDA Grant to Develop Oral Vaccine to Protect Farmed Fish - SynBioBeta

The Escalator: Eli Lilly, Nuvalent, Lumen Bioscience and more - Medical Marketing and Media

Lumen Bioscience data show needle free spirulina-produced vaccination protects against malaria - Labiotech.eu

Lumen Raises $13M for New Biotech Production Platform - SynBioBeta

Lumen Bioscience pursues oral biologic to prevent recurrent C. diff - drugdiscoverytrends.com

Seattle startup Lumen Bioscience to build algae manufacturing plant in former bakery - GeekWire

Lumen Bioscience Details 2022 Company and Facilities Growth, New Funding, and Clinical Pipeline Progress - PR Newswire

Seattle startup Lumen Bioscience is working with Google to make drugs using algae - GeekWire

Lumen Bioscience Receives Fast Track Designation from U.S. FDA for LMN-201 - PR Newswire

Lumen Bioscience awarded $16.2 million in DoD funding to advance LMN-201 through late-stage trials - PR Newswire

Lumen Bioscience and Novo Nordisk Enter into Research Collaboration to Explore Novel Strategies to Deliver Oral Biologics for Cardiometabolic Disease - PR Newswire

Lumen Bioscience Awarded $8.1 million from U.S. Department of Defense to Develop Fast-Acting, Intranasal Countermeasure Against Respiratory Viruses - PR Newswire

Lumen Bioscience Announces Publication in Nature Biotechnology Detailing Spirulina-Based Platform for Ultra-Large-Scale Production of Therapeutic Proteins - PR Newswire

Lumen Bioscience Hacks Spirulina to Generate Biologics - Genetic Engineering and Biotechnology News

Lumen Bioscience Raises $16M Series B Financing to Accelerate Clinical Development of Accessible Biologic Drugs - Business Wire

On the Horizon, Needle-Free Vaccines could Offer Better Protection and Access - BioSpace

Companies like Lumen Bioscience

Moonlight Bio

Hdt Bio

Kapoose Creek Bio

Parse Biosciences

A-Alpha Bio

Evolved Therapeutics

Systimmune

Adaptive Biotechnolo...

Shape Therapeutics Inc.

Starfish Neuroscience

Top Lumen Bioscience Employees

Brian Finrow

n/a

Sebastian Mikolajczak

n/a

Rob Carlson

Managing Director At Planetary…

John Morrow

Coo And Gc At Lumen Bioscience |…

Free Chrome Extension

Aero Online

Select data to include:

How It Works

Get a Free Account

Search the #1 Contact Database

Use our AI-Powered Email Finder

Have a look at Aeroleads Data